Anticancer therapeutic potential of benzofuran scaffolds

被引:44
作者
Abbas, Ashraf A. [1 ]
Dawood, Kamal M. [1 ]
机构
[1] Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt
基金
英国科研创新办公室;
关键词
BIOACTIVE BENZOFURAN; DIHYDROBENZOFURAN LIGNANS; BIOLOGICAL EVALUATION; ANTITUMOR AGENTS; DERIVATIVES; CANCER; DESIGN; INHIBITORS; DISCOVERY; AURONE;
D O I
10.1039/d3ra01383a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Benzofuran moiety is the main component of many biologically active natural and synthetic heterocycles. These heterocycles have unique therapeutic potentials and are involved in various clinical drugs. The reported results confirmed the extraordinary inhibitory potency of such benzofurans against a panel of human cancer cell lines compared with a wide array of reference anticancer drugs. Several publications about the anticancer potencies of benzofuran-based heterocycles were encountered. The recent developments of anticancer activities of both natural and synthetic benzofuran scaffolds during 2019-2022 are thoroughly covered. Many of the described benzofurans are promising candidates for development as anticancer agents based on their outstanding inhibitory potency against a panel of human cancer cells compared with reference anticancer drugs. These findings encourage medicinal chemists to explore new areas to improve human health and reduce suffering.
引用
收藏
页码:11096 / 11120
页数:25
相关论文
共 113 条
  • [1] Benzofuran as a promising scaffold for the synthesis of novel antimicrobial agents
    Abbas, Ashraf A.
    Dawood, Kamal M.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (12) : 1357 - 1376
  • [2] Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents
    Abbas, Hebat-Allah S.
    Abd El Karim, Somaia S.
    [J]. BIOORGANIC CHEMISTRY, 2019, 89
  • [3] Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds
    Abdelhafez, Omaima M.
    Ahmed, Eman Y.
    Latif, Nehad A. Abdel
    Arafa, Reem K.
    Abd Elmageed, Zakaria Y.
    Ali, Hamed I.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (07) : 1308 - 1319
  • [4] Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
    Abdelrahman, Mohamed A.
    Eldehna, Wagdy M.
    Nocentini, Alessio
    Ibrahim, Hany S.
    Almahli, Hadia
    Abdel-Aziz, Hatem A.
    Abou-Seri, Sahar M.
    Supuran, Claudiu T.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 298 - 305
  • [5] Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives
    Ahmed, Eman Y.
    Abdelhafez, Omaima M.
    Zaafar, Dalia
    Serry, Aya M.
    Ahmed, Yasmine H.
    El-Telbany, Rania Farag A.
    Abd Elmageed, Zakaria Y.
    Ali, Hamed, I
    [J]. ARCHIV DER PHARMAZIE, 2022, 355 (06)
  • [6] Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells
    Al-Sanea, Mohammad M.
    Al-Ansary, Ghada H.
    Elsayed, Zainab M.
    Maklad, Raed M.
    Elkaeed, Eslam B.
    Abdelgawad, Mohamed A.
    Bukhari, Syed Nasir Abbas
    Abdel-Aziz, Marwa M.
    Suliman, Howayda
    Eldehna, Wagdy M.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 987 - 999
  • [7] Aurone: A biologically attractive scaffold as anticancer agent
    Alsayari, Abdulrahman
    Bin Muhsinah, Abdullatif
    Hassan, Mohd Zaheen
    Ahsan, Mohammed Jawed
    Alshehri, Jaber Abdullah
    Begum, Naseem
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 166 : 417 - 431
  • [8] THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS
    AMSON, R
    SIGAUX, F
    PRZEDBORSKI, S
    FLANDRIN, G
    GIVOL, D
    TELERMAN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8857 - 8861
  • [9] Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase
    Antczak, Christophe
    Shum, David
    Bassit, Bhramdeo
    Frattini, Mark G.
    Li, Yueming
    de Stanchina, Elisa
    Scheinberg, David A.
    Djaballah, Hakim
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4528 - 4532
  • [10] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
    Asoh, Kohsuke
    Kohchi, Masami
    Hyoudoh, Ikumi
    Ohtsuka, Tatsuo
    Masubuchi, Miyako
    Kawasaki, Kenichi
    Ebiike, Hirosato
    Shiratori, Yasuhiko
    Fukami, Takaaki A.
    Kondoh, Osamu
    Tsukaguchi, Toshiyuki
    Ishii, Nobuya
    Aoki, Yuko
    Shimma, Nobuo
    Sakaitani, Masahiro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757